Dementia poses a major health challenge with no safe, affordable treatments to slow its progression.

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating whether Ambroxol -- a cough medicine used safely for decades in Europe -- can slow dementia in people with Parkinson's disease.

Published on June 30 in the prestigious JAMA Neurology, this 12-month clinical trial involving 55 participants with Parkinson's disease dementia (PDD) monitored memory, psychiatric symptoms and GFAP, a blood marker linked to brain damage. Parkinson's disease dementia causes memory loss, confusion, hallucinations and mood changes. About half of those diagnosed with Parkinson's develop dementia within 10 years, profoundly affecting patients, families and the health care system.

Led by Cognitive Neurologist Dr. Stephen Pasternak, the study gave one group daily Ambroxol while the other group received a placebo. "Our goal was to change the course of Parkinson's dementia," says Pasternak. "This early trial offers hope and provides a strong foundation for larger studies."

Key findings from the clinical trial include:

  • Ambroxol was safe, well-tolerated and reached therapeutic levels in the brain
  • Psychiatric symptoms worsened in the placebo group but remained stable in those taking Ambroxol.
  • Participants with high-risk GBA1 gene variants showed improved cognitive performance on Ambroxol
  • A marker of brain cell damage (GFAP) increased in the placebo group but stayed stable with Ambroxol, suggesting potential brain protection.

Although Ambroxol is approved in Europe for treating respiratory conditions and has a long-standing safety record -- including use at high doses and during pregnancy -- it is not approved for any use in Canada or the U.S.

"Current therapies for Parkinson's disease and dementia address symptoms but do not stop the underlying disease," explains Pasternak. "These findings suggest Ambroxol may protect brain function, especially in those genetically at risk. It offers a promising new treatment avenue where few currently exist."

Ambroxol supports a key enzyme called glucocerebrosidase (GCase), which is produced by the GBA1 gene. In people with Parkinson's disease, GCase levels are often low. When this enzyme doesn't work properly, waste builds up in brain cells, leading to damage. Pasternak learned about Ambroxol during a fellowship at The Hospital for Sick Children (SickKids) in Toronto, where it was identified as a treatment for Gaucher disease -- a rare genetic disorder in children caused by a deficiency of GCase.

He is now applying that research to explore whether boosting GCase with Ambroxol could help protect the brain in Parkinson's-related diseases. "This research is vital because Parkinson's dementia profoundly affects patients and families," says Pasternak. "If a drug like Ambroxol can help, it could offer real hope and improve lives."

Funded by the Weston Foundation, this study is an important step toward developing new treatments for Parkinson's disease and other cognitive disorders, including dementia with Lewy bodies. Pasternak and his team plan to start a follow-up clinical trial focused specifically on cognition later this year.

Read more …Cough medicine turned brain protector? Ambroxol may slow Parkinson’s dementia

In Japan, Shinrin Yoku or forest bathing has already been used for therapeutic applications, for instance, to lower blood pressure and stress levels. For their study, the researchers wanted to find out whether forest bathing - consciously immersing oneself in nature - can also be effective when done virtually, and focused on whether the positive effect is stronger when several senses are addressed simultaneously.

For the project, a high-quality 360° VR video was produced in Europe's largest Douglas fir forest, the Sonnenberg nature reserve near Parchim - complete with original sounds and the scent of essential oils from the Douglas fir. The participants experienced the virtual forest scenery either as a full sensory experience (with images, sound and scent) or in a reduced form whereby forest stimuli appealing to just a single sense - visual, auditory or olfactory - were used. In variants where only hearing or scent was activated, participants were placed in a neutral virtual environment to minimize visual stimuli and the influence of VR technology.

Significantly better effect with sensory combination

More than 130 participants were first put into an acute stress situation using stress-inducing images. Then, equipped with VR glasses, they experienced one of the four forest stimulation/ bathing variants. The results show that the combination of all three sensory stimuli led to a significantly greater improvement in mood and a stronger feeling of connection with nature compared to when individual sensory stimuli were presented. In addition to positive effects on mood, there were also limited improvements in working memory - the cognitive function that enables us to store, process and retrieve information in the short term.

However, the researchers point out that the effects are area-specific and cannot yet be considered universally valid. Further studies with larger samples are needed to confirm the results and provide a better understanding of the mechanisms behind the restorative effects of virtual nature experiences.

"We can already say that digital nature experiences can absolutely produce an emotional effect - even if they don't replace actual nature," reports Leonie Ascone, lead author of the study and researcher in the Neuronal Plasticity working group at the University Medical Center Hamburg-Eppendorf (UKE).

Potential for clinics, waiting rooms and urban spaces

Simone Kühn, head of the study and Director of the Center for Environmental Neuroscience at the Max Planck Institute for Human Development, adds: "Especially in places with limited access to nature - such as clinics, waiting areas or urban interiors - multisensory VR applications or targeted nature staging could support mental well-being. The images, sounds and scents of nature offer previously underestimated potential for improving mood and mental performance in everyday situations." Kühn conducts intensive research into the effects of the environment on the human brain and, together with colleagues from universities in Vienna, Exeter and Birmingham, was recently able to prove that just from watching nature videos, patients perceive physical pain as less intense (Steininger et al., 2025).

In brief:

  • Forest bathing in Virtual Reality improves emotional well-being and increases connectedness to nature, particularly when several senses (sight, hearing, smell) are simultaneously engaged
  • The study used a 360° VR forest video complete with original sounds and the scent of Douglas fir essential oils
  • There is potential for application especially in clinical, urban and other environments with limited access to nature
Read more …Multisensory VR forest reboots your brain and lifts mood—study confirms

An international research team led by scientists from the University of Vienna has uncovered new insights into how specialized cell types and communication networks at the interface between mother and fetus evolved over millions of years. These discoveries shed light on one of nature's most remarkable innovations - the ability to sustain a successful pregnancy. The findings have just been published in Nature Ecology & Evolution.

Pregnancy that lasts long enough to support full fetal development is a hallmark evolutionary breakthrough of placental mammals - a group that includes humans. At the center of this is the fetal-maternal interface: the site in the womb where a baby's placenta meets the mother's uterus, and where two genetically distinct organisms - mother and fetus - are in intimate contact and constant interaction. This interface has to strike a delicate balance: intimate enough to exchange nutrients and signals, but protected enough to prevent the maternal immune system from rejecting the genetically "foreign" fetus.

To uncover the origins and mechanisms behind this intricate structure, the team analyzed single-cell transcriptomes - snapshots of active genes in individual cells - from six mammalian species representing key branches of the mammalian evolutionary tree. These included mice and guinea pigs (rodents), macaques and humans (primates), and two more unusual mammals: the tenrec (an early placental mammal) and the opossum (a marsupial that split off from placental mammals before they evolved complex placentas).

A Cellular "Atlas of Mammal Pregnancy"

By analyzing cells at the fetal-maternal interface, the researchers were able to trace the evolutionary origin and diversification of the key cell types involved. Their focus was on two main players: placenta cells, which originate from the fetus and invade maternal tissue, and uterine stromal cells, which are of maternal origin and respond to this invasion.

Using molecular biology tools, the team identified distinct genetic signatures - patterns of gene activity unique to specific cell types and their specialized functions. Notably, they discovered a genetic signature associated with the invasive behavior of fetal placenta cells that has been conserved in mammals for over 100 million years. This finding challenges the traditional view that invasive placenta cells are unique to humans, and reveals instead that they are a deeply conserved feature of mammalian evolution. During this time, the maternal cells weren't static, either. Placental mammals, but not marsupials, were found to have acquired new forms of hormone production, a pivotal step toward prolonged pregnancies and complex gestation, and a sign that the fetus and the mother could be driving each other's evolution.

Cellular Dialogue: Between Cooperation and Conflict

To better understand how the fetal-maternal interface functions, the study tested two influential theories about the evolution of cellular communication between mother and fetus.

The first, the "Disambiguation Hypothesis," predicts that over evolutionary time, hormonal signals became clearly assigned to either the fetus or the mother - a possible safeguard to ensure clarity and prevent manipulation. The results confirmed this idea: certain signals, including WNT proteins, immune modulators, and steroid hormones, could be clearly traced back to one source tissue.

The second, the "Escalation Hypothesis" (or "genomic Conflict"), suggests an evolutionary arms race between maternal and fetal genes - with, for example, the fetus boosting growth signals while the maternal side tries to dampen them. This pattern was observed in a small number of genes, notably IGF2, which regulates growth. On the whole, evidence pointed to fine-tuned cooperative signaling.

"These findings suggest that evolution may have favored more coordination between mother and fetus than previously assumed," says Daniel J. Stadtmauer, lead author of the study and now a researcher at the Department of Evolutionary Biology, University of Vienna. "The so-called mother-fetus power struggle appears to be limited to specific genetic regions. Rather than asking whether pregnancy as a whole is conflict or cooperation, a more useful question may be: where is the conflict?"

Single-Cell Analysis: A Key to Evolutionary Discovery

The team's discoveries were made possible by combining two powerful tools: single-cell transcriptomics - which captures the activity of genes in individual cells - and evolutionary modeling techniques that help scientists reconstruct how traits might have looked in long-extinct ancestors. By applying these methods to cell types and their gene activity, the researchers could simulate how cells communicate in different species, and even glimpse how this dialogue has evolved over millions of years.

"Our approach opens a new window into the evolution of complex biological systems - from individual cells to entire tissues," says Silvia Basanta, co-first author and researcher at the University of Vienna. The study not only sheds light on how pregnancy evolved, but also offers a new framework for tracking evolutionary innovations at the cellular level - insights that could one day improve how we understand, diagnose, or treat pregnancy-related complications.

The research was conducted in the labs of Mihaela Pavličev at the Department of Evolutionary Biology, University of Vienna, and Günter Wagner at Yale University. Wagner is Professor Emeritus at Yale and a Senior Research Fellow at the University of Vienna. The study was supported by the John Templeton Foundation and the Austrian Science Fund (FWF).

Read more …Pregnancy’s 100-million-year secret: Inside the placenta’s evolutionary power play

More Articles …